ciprofloxacin has been researched along with Leprosy, Borderline in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Leprosy, Borderline: A form of LEPROSY in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zorbas, P | 1 |
| Kontochristopoulos, G | 1 |
| Detsi, I | 1 |
| Apostolakis, E | 1 |
| Kouris, N | 1 |
| Katsambas, A | 1 |
1 other study available for ciprofloxacin and Leprosy, Borderline
| Article | Year |
|---|---|
Borderline tuberculoid leprosy coexisting with systemic lupus erythematosus.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Female; Foot Ulcer; Humans; Leprosy, | 1999 |